| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.025 | 0.9 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.045 | 0.9 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.0074 | 0.9 |